Effect of methyltestosterone administration on microsomal drug metabolism in aging rats

Area of Science:

• Pharmacology
• Hepatology
• Aging Research

Background:

• The hepatic microsomal drug-metabolizing system shows age-related declines in activity.
• Methyltestosterone is an androgen with potential effects on liver function.

Purpose of the Study:

• To investigate the impact of methyltestosterone on the aged rat liver drug-metabolizing system.
• To determine if methyltestosterone can counteract age-associated decreases in specific enzyme activities.

Main Methods:

• Administration of methyltestosterone (100 mg/kg/day for four days) to old male rats.
• Assay of cytochrome P-450 content, cytochrome c reductase activity, and specific N-demethylase and O-demethylase activities.
• Comparison of enzyme activities between treated old rats, untreated old rats, and young-adult rats.

Main Results:

• Methyltestosterone treatment did not alter age-related decreases in cytochrome P-450 content, cytochrome c reductase activity, or benzphetamine N-demethylase activity.
• The androgen significantly induced nitroanisole O-demethylase and aniline hydroxylase activities.
• Aniline hydroxylase activity in treated old rats was restored to levels observed in young-adult animals.

Conclusions:

• Methyltestosterone partially modulates the aged rat hepatic microsomal drug-metabolizing system.
• The androgen can enhance specific drug-metabolizing enzyme activities, suggesting a potential for targeted intervention in aging liver function.
• Age-related declines in certain drug metabolism pathways may not be fully reversible with methyltestosterone treatment.